Back to newsroom
News
Michelle Capobianco speaks with Rick Zamperin, 900 CHML, on the desperate need to raise the rate of pancreatic cancer survival

November 16, 2022

Image of RASONQUE (daraxonrasib) bottle and carton packaging.

Pancreatic Cancer Canada CEO Michelle Capobianco speaks with Rick Zamperin, 900CHML, on the desperate need to raise the rate of pancreatic cancer survival

Pancreatic Cancer Canada CEO Michelle Capobianco speaks with 900CHML host Rick Zamperin about the state of pancreatic cancer, common misconceptions about the disease, and the desperate need for greater awareness and support to raise the rate of survival.Listen to the full segment using the audio player on the right. 

Be part of the force driving answers for this devastating disease.

Make a donation towards pancreatic cancer research and support programs.

donate today

Keep in the loop:

Read more PCNA News:

discover more

Research
Six Months is a Start

Research
We Asked. You Shared. Here’s What We Do Next.

August 19, 2026

Research
It's Probably Just Menopause...